Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
On the Maintenance Phase episode, The Body Mass Index , Aubrey Gordon explains that, What happens is because weve now changed the standards, because it looks like there is an epidemic happening now that wasnt there before, it opens the floodgates [Roche and Abbott] need to establish that weight loss is a going concern for medicine, and that a fuck ton of people need medical intervention to lose weight And that is so that Roche and Abbott have customers to buy Meridia and Orlistat
If weight loss becomes a pill away, How do we balance medical innovation with lifestyle intervention
There is no clinical trial data here, but the clinical concern is real and growing
Increasing growth hormone and IGF-1 levels may carry potential risks, including worsening insulin resistance in some individuals and, theoretically, stimulating the growth of existing cancers
